Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Correction: Plasma Aβ42/p-Tau217 ratio and p-Tau217 independently predict CSF-defined Alzheimer's disease pathology in a Brazilian admixed cohort.

Frontiers in aging neuroscience·2026
Same author

Neurovascular and inflammatory effects of biperiden in the acute phase of moderate traumatic brain injury: evidence from a non-human primate model.

Scientific reports·2026
Same author

Plasma Aβ42/p-Tau217 ratio and p-Tau217 independently predict CSF-defined Alzheimer's disease pathology in a Brazilian admixed cohort.

Frontiers in aging neuroscience·2026
Same author

Fibronectin type III domain-containing protein 5/irisin in extracellular vesicles is reduced in older individuals.

Brain communications·2026
Same author

The importance of sleep assessment in quality of life research in rare epilepsy syndromes.

Epilepsy & behavior : E&B·2026
Same author

Exploring the Gut-Brain Connection: Are Probiotics the Next Frontier in Alzheimer's Disease Treatment?

Probiotics and antimicrobial proteins·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Michele Longoni Calio1,2,3, Luis E Santos4, Amanda Cristina Mosini3

  • 1Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

像GFAP和NfL这样的血清生物标志物可以帮助理解创伤性脑损伤 (TBI) 和阿尔茨海默病 (AD) 之间的联系. 超敏感测量显示这些标记与损伤严重程度和进展相关,有助于个性化诊断.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物发现发现
  • 老年学是一门学科.

背景情况:

  • 创伤性脑损伤 (TBI) 是已知的阿尔茨海默病 (AD) 的风险因素,但根本机制尚未完全理解.
  • 识别神经元和天体细胞损伤的基于血液的生物标志物对于预测神经退行症和实现精准医学至关重要.
  • 这项研究调查了血清生物标志物,以探索它们与TBI严重程度,性别特异性反应以及与AD病理学的相关性之间的联系.

研究的目的:

  • 使用单分子阵列 (SIMOA) 平台评估血清生物标志物.
  • 探索这些生物标志物与TBI严重程度,性别,年龄和受伤后的时间的关联.
  • 调查这些生物标志物对AD中发现的神经退行过程的潜在相关性.

主要方法:

  • 一个来自III期临床试验 (NCT01048138) 的123名急性TBI患者的亚分析.
  • 在多个时间点使用SIMOA分析血清样本,以检测包括Tau,NfL,GFAP和UCHL1在内的生物标志物.
  • 生物标志物概况在治疗组之间进行了比较,包括TBI严重程度,性别,年龄和受伤后的时间,并对AD相关性的额外分析.

主要成果:

  • GFAP和NfL与年龄,性别,TBI严重程度和时间进展有很强的相关性,表明了星系细胞和轴突损伤.
  • UCHL1水平也与创伤严重程度,性别和受伤后的时间有关,尽管不如NfL和GFAP那么显著.
  • 观察到性别特异性差异,女性的Tau,GFAP和UCHL1水平较高,但NfL水平较低. 老年患者表现出NfL和GFAP的增加.

结论:

  • 血清生物标志物GFAP和NfL在阐明TBI和AD之间的分子联系方面显示出希望.
  • SIMOA技术允许精确量化,为TBI-to-AD时间表和长期神经退行提供了洞察力.
  • 这些发现支持个性化的诊断方法和治疗监测TBI和AD.